Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Return on Invested Capital (2022 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Return on Invested Capital for 4 consecutive years, with 1.28% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital rose 1414.0% to 1.28% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.28% through Dec 2025, up 1414.0% year-over-year, with the annual reading at 2.27% for FY2025, 49.0% up from the prior year.
  • Return on Invested Capital for Q4 2025 was 1.28% at Rhythm Pharmaceuticals, up from 2.55% in the prior quarter.
  • The five-year high for Return on Invested Capital was 0.76% in Q1 2022, with the low at 28.61% in Q2 2025.
  • Average Return on Invested Capital over 4 years is 6.96%, with a median of 2.55% recorded in 2025.
  • Peak annual rise in Return on Invested Capital hit 1414bps in 2025, while the deepest fall reached -2332bps in 2025.
  • Over 4 years, Return on Invested Capital stood at 0.76% in 2022, then dropped by -27bps to 0.96% in 2023, then crashed by -1510bps to 15.42% in 2024, then surged by 92bps to 1.28% in 2025.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 1.28%, 2.55%, and 28.61% for Q4 2025, Q3 2025, and Q2 2025 respectively.